Healthcare -
Biotechnology - NASDAQ - US
$ 7.37
3.08 %
$ 365 M
Market Cap
-1.47
P/E
RGNX - OTHER LONG-TERM ASSETS
Other Long-term Assets RGNX - REGENXBIO Inc.
7.54 M
LAST VALUE
-16.14%
2 YEAR CAGR
-22.16%
5 YEAR CAGR
0.00%
10 YEAR CAGR